Perfusion Systems Market - By Technique (Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Component (Oxygenators, Heart-Lung Machine, Perfusion Pumps, Monitoring System), By Application, By End-use & Forecast, 2023

Description

List of Tables

Global Perfusion Systems Market will witness 4.6% CAGR between 2023 and 2032. The increasing prevalence of cardiovascular and respiratory diseases necessitates advanced perfusion systems for organ transplants and surgeries. Advancements in medical technology have led to more sophisticated and efficient perfusion systems. Rising FDA approvals for the latest technological devices involving or associated with profusions support market growth.

For instance, in August 2023, LivaNova PLC, a leading medical technology company, announced the attainment of regulatory clearances from the FDA and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM). Integrated into the Essenz™ Perfusion System, the monitor enables perfusionists to access and manage blood parameters conveniently from the system's cockpit, eliminating the need for extra monitors or holders. The rising aging population contributes to the demand for organ transplantation, further fueling market growth. Additionally, the growing awareness of the importance of perfusion in healthcare and the expansion of organ transplant programs globally drive the perfusion systems market outlook.

The overall Perfusion Systems Market is classified based on technique, application, and region.

The normothermic machine perfusion segment will undergo significant development from 2023 to 2032. This advanced technique preserves and evaluates organs at near-normal body temperatures during transplantation, enhancing their viability and functionality. Normothermic machine perfusion is becoming increasingly crucial in transplant procedures, as it allows for better organ assessment and extends the window of time for successful transplantation, driving the contribution of such systems in the perfusion systems market revenue.

The cell perfusion system segment will register a commendable CAGR from 2023 to 2032. These specialized devices are vital in cell culture and tissue engineering applications, providing a controlled environment for nurturing cells and tissues. Researchers and biotechnologists rely on cell perfusion systems to replicate physiological conditions, study cell behavior, and develop advanced therapies. The demand for precise and efficient cell perfusion technology continues to drive the perfusion systems market growth.

Europe Perfusion Systems Industry will showcase an appreciable CAGR from 2023 to 2032. The region's well-established healthcare infrastructure and a growing number of organ transplant procedures drive the need for advanced perfusion systems. Normothermic machine perfusion and innovative technologies are gaining prominence in European healthcare, further contributing to market growth. With a focus on improving transplant outcomes and addressing organ shortages, Europe remains a pivotal market for perfusion systems in the medical field.

Product Code: 6227

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Perfusion systems industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends
2.4 Technique trends
2.5 Component trends
2.6 Application trends
2.7 End-use trends

Chapter 3 Perfusion Systems Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases
  - 3.2.1.2 Rising number of organ transplantations
  - 3.2.1.3 Increasing incidence of multiple organ failure among ageing population
  - 3.2.1.4 Rising awareness regarding advance perfusion systems
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of perfusion systems
  - 3.2.2.2 Ethical Concerns related to cell - based research
3.3 Growth potential analysis
- 3.3.1 By technique
- 3.3.2 By component
- 3.3.3 By application
- 3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Key market trends
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 Value chain analysis
3.11 Gap Analysis
3.12 Porter's analysis
3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022

Chapter 5 Perfusion Systems Market Size and Forecast, By Technique (USD Million)

5.1 Key trends, by technique
5.2 Hypothermic machine perfusion
5.3 Normothermic machine perfusion

Chapter 6 Perfusion Systems Market Size and Forecast, By Component (USD Million)

6.1 Key trends, by component
6.2 Oxygenators
6.3 Heart-lung machine
6.4 Perfusion pumps
6.5 Monitoring system
6.6 Bioreactor perfusion system
6.7 Others

Chapter 7 Perfusion Systems Market Size and Forecast, By Application (USD Million)

7.1 Key trends, by application
7.2 Cardiopulmonary perfusion system
7.3 Cell perfusion system
7.4 Ex-vivo organ perfusion system

Chapter 8 Perfusion Systems Market Size and Forecast, By End-use (USD Million)

8.1 Key trends, by end-use
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Others

Chapter 9 Perfusion Systems Market Size and Forecast, By Region (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Sweden
- 9.3.7 Poland
- 9.3.8 The Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Indonesia
- 9.4.7 Thailand
- 9.4.8 Philippines
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Colombia
- 9.5.5 Chile
- 9.5.6 Peru
9.6 MEA
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Israel
- 9.6.5 Egypt
- 9.6.6 Turkey

Chapter 10 Company Profiles

10.1 ALA Scientific Instruments, Inc.
10.2 Bioptechs Inc.
10.3 Cytiva
10.4 Getinge AB
10.5 Harvard Bioscience, Inc.
10.6 Lifeline Scientific, Inc.
10.7 LivaNova
10.8 Medtronic, plc
10.9 Merck KGaA
10.10 Nipro Corporation
10.11 Repligen Corporation
10.12 Spectrum Laboratories, Inc.
10.13 Terumo Corporation
10.14 XENIOS AG